CyTOF-based profiling of circulating tumor cells predicts aggressiveness and therapy response in SCLC liquid biopsies at a personalized level
Mukulika Bose, Cole Ruoff, Shafqat Ehsan, Catherine Allison Stewart, Alberto José da Silva Duarte, Sayantan Bhattacharyya, Jiaqi Li, Benedict Anchang, Thomas Welte, Ashley Victorian, Fabiola Ester Lujan, Lixia Diao, Jing Wang, Ken Chen, Bingnan Zhang, , Loukia Georgiou Karacosta
This study uses CyTOF to profile circulating tumor cells in SCLC patients, identifying subtype-specific markers and treatment response correlations.
bioRxiv · Dec 19, 2025 · PreprintCancer Biology